Chronic Renal Failure Treated with Kidney Specific Stem Cells Derived From Umbilical Cord Stem Cells

In a randomized controlled study 300 patients were studied suffering from chronic kidney failure.All of these patients were undergoing dialysis.200 patients were having dialysis thrice weekly and 100 were having twice weekly dialysis.All of these patients were transfused with 40 million kidney specific stem cells which were modified from hemopoeitic umbilical cord stem cells.2 weeks post stem cell transfusion the serum creatinine levels of all patients started to decrease by one to two points.All these patients were advised to keep up with their dialysis routine as before.Every week a decrease in serum creatinine level and increase in eGFR was noted bit by bit and by the end of 3 months almost all of these patients attained a serum creatinine level of less than 5 and eGFR of around 50 hence halting the need for dialysis although still they were having kidney failure.256 patients returned to normal creatinine less than 1.3 and eGFR above 60 by the end of 7 months post stem cell.Kidney stem cell boosters included tab furosemide 40 mg bd and serum anguilae 30.